S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.34
+1.66
+9.95%
PBH · Prestige Consumer Healthcare Inc.
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
Prestige Consumer Healthcare Inc (PBH)
NEW YORK STOCK EXCHANGE, INC.
Pharmaceuticals
$47.91
-1.34
(-2.71%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$47.91
$47.49
$48.65
52-WEEK RANGE
$47.91
$42.62
$71.07
What's happening
- PBH is down 2.71% today, trading at $47.91. — Live quote
- Volume today (33,442) is well below its 3-month average of 586,290. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.98 actual vs. $0.89 estimated (+10.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 4
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (10 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
PBH
-19.99%
vs S&P 500
-32.76%
1-YEAR RETURN
PBH
-20.62%
vs S&P 500
-35.18%
6-MONTH RETURN
PBH
-13.48%
3-MONTH RETURN
PBH
+0.67%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q1 2027)
$0.98
Est. $0.89
BEAT +10.0%
2026-07-26 (Q2 2026)
$0.98
Est. $0.89
BEAT +10.0%
2026-04-26 (Q1 2026)
$1.23
Est. $1.40
MISS -12.4%
2025-04-26 (Q4 2025)
$1.32
Est. $1.31
BEAT +0.6%
Valuation Measures & Ratios
Enterprise Value4$4.21B
Forward P/E510.45
PEG Ratio6—
Price / Sales (TTM1)2.05
Price / Book71.17
EV4 / Revenue3.81
EV4 / EBITDA13.52
Profit Margin15.57%
Operating Margin26.26%
Return on Equity (ROE8)9.22%
Return on Assets (ROA9)4.59%
Avg Volume (3M)586,290
Quarterly history (5 periods)
| Measure | Jun '26 | Dec '25 | Sep '25 | Jun '25 | Dec '24 |
|---|---|---|---|---|---|
| Market cap | $2.26B | $2.97B | $3.07B | $3.99B | $3.91B |
| P/E | 13.67 | 15.04 | 14.95 | 18.82 | 17.97 |
| Price/Sales | 2.11 | 2.71 | 2.79 | 3.66 | 3.48 |
| Price/Book | 1.18 | 1.62 | 1.68 | 2.15 | 2.19 |
| EV/Revenue | 3.91 | 2.65 | 2.68 | 3.53 | 4.32 |
| EV/EBITDA | 13.18 | 8.17 | 8.23 | — | — |
| ROE | 8.64% | 10.79% | 11.24% | 11.42% | 12.16% |
| ROA | 3.62% | 5.65% | 5.96% | 6.18% | 6.53% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short4,644,472
Change from Prior Settlement-3.12%
% of Float—
Days to Cover (Short Ratio)6.60
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 6.5% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 15.6%. Finnhub fundamentals ↗
Potential concerns
- Trailing 52-week price return is -20.6%. Finnhub market metrics ↗
- Latest SEC filing is Form 8-K, filed 2026-08-14; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on PBH
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Dec '25 | Sep '25 | Jun '25 | Dec '24 | Sep '24 | Jun '24 | Dec '23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $265.7M | $283.4M | $274.1M | $249.5M | $290.3M | $283.8M | $267.1M | $282.7M |
| Gross profit | $136.2M | $157.4M | $151.6M | $140.3M | $161.0M | $157.4M | $146.0M | $157.9M |
| Operating income | $52.5M | $82.5M | $79.7M | $71.8M | $92.0M | $84.3M | $72.0M | $86.8M |
| Net income | $29.2M | $46.7M | $42.2M | $47.5M | $61.0M | $54.4M | $49.1M | $53.0M |
| EPS (diluted) | $0.61 | $0.97 | $0.86 | $0.95 | $1.22 | $1.09 | $0.98 | $1.06 |
| EPS (basic) | $0.61 | $0.98 | $0.86 | $0.96 | $1.23 | $1.10 | $0.98 | $1.07 |
| Operating margin | $20 | $29 | $29 | $29 | $32 | $30 | $27 | $31 |
| Net margin | $11 | $16 | $15 | $19 | $21 | $19 | $18 | $19 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B |
| Total liabilities | $2.65B | $1.61B | $1.67B | $1.62B | $1.58B | $1.57B | $1.54B | $1.59B |
| Stockholders' equity | $1.92B | $1.89B | $1.83B | $1.82B | $1.86B | $1.83B | $1.79B | $1.73B |
| Total current assets | $496.8M | $431.5M | $433.4M | $497.4M | $480.5M | $448.3M | $377.2M | $380.7M |
| Total current liabilities | $153.8M | $120.9M | $139.6M | $134.6M | $109.7M | $106.6M | $102.5M | $106.9M |
| Cash & equivalents | $89.1M | $63.9M | $62.4M | $119.1M | $139.5M | $97.9M | $50.9M | $51.5M |
| Accounts receivable | $187.4M | $191.9M | $190.5M | $199.0M | $168.4M | $194.3M | $167.3M | $163.5M |
| Inventory | $190.2M | $159.1M | $163.6M | $159.0M | $153.1M | $147.7M | $151.5M | $156.2M |
| Property, plant & equipment | $117.2M | $121.7M | $128.2M | $73.1M | $73.8M | $74.5M | $73.5M | $74.9M |
| Goodwill | $650.8M | $581.1M | $581.2M | $528.4M | $528.3M | $527.4M | $527.2M | $529.2M |
| Intangible assets | $3.24B | $2.30B | $2.30B | $2.29B | $2.29B | $2.30B | $2.31B | $2.32B |
| Other non-current assets | $13.4M | $10.9M | $3.8M | $3.4M | $3.0M | $3.3M | $6.3M | $6.7M |
| Accounts payable | $36.8M | $22.8M | $42.9M | $41.9M | $22.2M | $18.9M | $19.5M | $31.2M |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Short-term debt | $10.4M | $0 | — | — | — | — | — | — |
| Long-term debt | $2.01B | $994.0M | — | — | — | — | $1.00B | $1.06B |
| Other non-current liabilities | $5.6M | $5.6M | $5.7M | $5.4M | $5.4M | $5.4M | $5.0M | $5.1M |
| Common stock & paid-in capital | $563.0K | $562.0K | $562.0K | $562.0K | $561.0K | $560.0K | $559.0K | $557.0K |
| Retained earnings | $1.78B | $1.75B | $1.69B | $1.65B | $1.60B | $1.56B | $1.51B | $1.44B |
| Accumulated other comprehensive income (loss) | -$29.7M | -$28.4M | -$30.2M | -$31.6M | -$32.3M | -$37.7M | -$40.2M | -$26.5M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $70.8M | $42.8M | $78.3M | $57.5M | $79.0M | $61.8M | $65.1M | $69.8M |
| Investing cash flow | -$1.06B | -$3.4M | -$128.6M | -$2.9M | -$1.9M | -$3.5M | -$9.8M | -$2.0M |
| Financing cash flow | $1.02B | -$38.1M | -$6.7M | -$74.9M | -$36.3M | -$11.5M | -$53.9M | -$51.2M |
| Free cash flow | $67.1M | $37.6M | $75.3M | $55.4M | $78.2M | $58.4M | $63.5M | $67.8M |
| Capital expenditures | $3.7M | $5.2M | $3.0M | $2.1M | $838.0K | $3.5M | $1.6M | $2.0M |
| Depreciation & amortization | $8.8M | $8.4M | $7.6M | $7.7M | $7.7M | $7.3M | $6.9M | $7.9M |
| Share-based compensation | $4.0M | $2.6M | $2.7M | $1.8M | $3.7M | $2.7M | $2.9M | $2.1M |
| Deferred income taxes | $193.0K | -$4.1M | $3.6M | $17.4M | $5.8M | $7.1M | $2.9M | $3.8M |
| Change in accounts receivable | -$3.5M | $1.6M | -$495.0K | $29.9M | -$27.3M | $25.2M | $6.3M | -$8.8M |
| Change in inventory | $2.8M | -$5.5M | -$3.2M | $5.8M | $4.4M | -$4.1M | -$3.1M | $3.4M |
| Change in accounts payable | $13.4M | -$18.6M | -$4.1M | $19.8M | $2.8M | -$560.0K | -$11.3M | -$8.2M |
| Other investing activities | — | $0 | $0 | $827.0K | $1.1M | $0 | $0 | $0 |
| Share repurchases | $0 | $690.0K | $45.8M | $75.0M | $34.8M | $11.3M | $2.4M | $11.8M |
| Debt issued | $1.04B | — | — | — | $0 | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $2.7M | $62.0K | $44.0K | $162.0K | $4.1M | $0 | $0 | $31.0K |
| Other financing activities | -$1.5M | $0 | -$246.0K | — | $0 | $0 | $0 | — |
Income statement
| Line item | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 |
|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B |
| Gross profit | $595.6M | $634.5M | $624.4M | $625.3M | $620.6M |
| Operating income | $309.4M | $336.8M | $342.4M | -$22.4M | $329.9M |
| Net income | $190.3M | $214.6M | $209.3M | -$82.3M | $205.4M |
| EPS (diluted) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
| EPS (basic) | $3.93 | $4.32 | $4.21 | $-1.65 | $4.09 |
| Operating margin | $28 | $30 | $30 | -$2 | $30 |
| Net margin | $17 | $19 | $19 | -$7 | $19 |
Balance sheet
| Line item | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 |
|---|---|---|---|---|---|
| Total assets | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B |
| Total liabilities | $1.61B | $1.57B | $1.66B | $1.91B | $2.09B |
| Stockholders' equity | $1.89B | $1.83B | $1.66B | $1.45B | $1.58B |
| Total current assets | $431.5M | $448.3M | $375.0M | $391.7M | $293.3M |
| Total current liabilities | $120.9M | $106.6M | $117.0M | $160.7M | $143.4M |
| Cash & equivalents | $63.9M | $97.9M | $46.5M | $58.5M | $27.2M |
| Accounts receivable | $191.9M | $194.3M | $176.8M | $167.0M | $139.3M |
| Inventory | $159.1M | $147.7M | $138.7M | $162.1M | $120.3M |
| Property, plant & equipment | $121.7M | $74.5M | $76.5M | $70.4M | $71.3M |
| Goodwill | $581.1M | $527.4M | $527.7M | $527.6M | $579.0M |
| Intangible assets | $2.30B | $2.30B | $2.32B | $2.34B | $2.70B |
| Other non-current assets | $10.9M | $3.3M | $5.7M | $3.0M | $3.3M |
| Accounts payable | $22.8M | $18.9M | $39.0M | $62.7M | $55.8M |
| Accrued liabilities | — | — | — | — | — |
| Long-term debt | — | — | $1.13B | $1.35B | $1.48B |
| Other non-current liabilities | $5.6M | $5.4M | $9.2M | $8.2M | $7.5M |
| Common stock & paid-in capital | $562.0K | $560.0K | $555.0K | $548.0K | $544.0K |
| Retained earnings | $1.75B | $1.56B | $1.34B | $1.13B | $1.21B |
| Accumulated other comprehensive income (loss) | -$28.4M | -$37.7M | -$34.5M | -$31.6M | -$19.0M |
Cash flow
| Line item | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 |
|---|---|---|---|---|---|
| Operating cash flow | $257.6M | $251.5M | $248.9M | $229.7M | $259.9M |
| Investing cash flow | -$136.8M | -$17.5M | -$20.1M | -$11.6M | -$256.5M |
| Financing cash flow | -$156.1M | -$182.1M | -$241.0M | -$185.8M | -$7.6M |
| Free cash flow | $246.4M | $243.3M | $239.4M | $221.9M | $250.3M |
| Capital expenditures | $11.2M | $8.2M | $9.6M | $7.8M | $9.6M |
| Depreciation & amortization | $31.3M | $30.2M | $30.7M | $32.6M | $32.1M |
| Share-based compensation | $10.8M | $11.2M | $14.0M | $12.4M | — |
| Deferred income taxes | $22.7M | $14.4M | $23.1M | -$60.8M | $10.0M |
| Change in accounts receivable | $3.7M | $16.3M | $6.3M | $24.9M | $24.7M |
| Change in inventory | $1.6M | $9.3M | -$24.4M | $42.2M | -$663.0K |
| Change in accounts payable | -$151.0K | -$19.4M | -$25.0M | $7.3M | $9.2M |
| Other investing activities | $1.9M | $978.0K | $0 | $3.8M | -$177.0K |
| Share repurchases | $156.3M | $51.5M | $25.0M | $50.0M | $0 |
| Debt repaid | — | — | — | — | — |
| Tax withholding on stock comp | $4.3M | $5.8M | $5.5M | $5.5M | $2.9M |
| Other financing activities | -$246.0K | $0 | $0 | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding PBH as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-01-06 to 2026-08-04
Recent transactions
- Insiders have net sold 2,209 shares over the last 182 days, across 0 purchases and 4 sales.
- Most recent: ZIER DAWN M. (Director) — Grant / award of 2,981 shares on 2026-08-04.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)2,209 sh(4 txns)
Net Shares-2,209
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| ZIER DAWN M. | Director | Grant / award | 2026-08-04 | 2,981 |
| Kelly John F. | Director | Grant / award | 2026-08-04 | 2,981 |
| DArecca James | Director | Grant / award | 2026-08-04 | 2,981 |
| Clark Celeste A. | Director | Grant / award | 2026-08-04 | 2,981 |
| BYOM JOHN E | Director | Grant / award | 2026-08-04 | 2,981 |
| Zerillo Jeffrey | Senior VP Operations | Open market sale | 2026-05-11 | 351 |
| Sacco Christine | CFO & COO | Tax withholding | 2026-05-07 | 991 |
| Lombardi Ronald M. | Chief Executive Officer | Tax withholding | 2026-05-07 | 2,543 |
| Mekhail Adel | EVP, Marketing & Sales | Tax withholding | 2026-05-07 | 487 |
| P'Pool William | See Remarks | Grant / award | 2026-05-04 | 3,675 |
| Rosado Jose Luis | See Remarks | Grant / award | 2026-01-06 | 3,426 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-04 | ZIER DAWN M. | Director | Grant / award | 2,981 | $0.00 |
| 2026-08-04 | Kelly John F. | Director | Grant / award | 2,981 | $0.00 |
| 2026-08-04 | DArecca James | Director | Grant / award | 2,981 | $0.00 |
| 2026-08-04 | Clark Celeste A. | Director | Grant / award | 2,981 | $0.00 |
| 2026-08-04 | BYOM JOHN E | Director | Grant / award | 2,981 | $0.00 |
| 2026-05-11 | Zerillo Jeffrey | Senior VP Operations | Open market sale | 351 | $52.28 |
| 2026-05-07 | Zerillo Jeffrey | Senior VP Operations | Tax withholding | 351 | $54.59 |
| 2026-05-07 | Zerillo Jeffrey | Senior VP Operations | Open market sale | 305 | $54.36 |
| 2026-05-07 | Sacco Christine | CFO & COO | Tax withholding | 991 | $54.59 |
| 2026-05-07 | Lombardi Ronald M. | Chief Executive Officer | Tax withholding | 2,543 | $54.59 |
| 2026-05-07 | Mekhail Adel | EVP, Marketing & Sales | Tax withholding | 487 | $54.59 |
| 2026-05-05 | Zerillo Jeffrey | Senior VP Operations | Tax withholding | 307 | $55.75 |
| 2026-05-05 | Zerillo Jeffrey | Senior VP Operations | Open market sale | 1,207 | $54.99 |
| 2026-05-05 | Sacco Christine | CFO & COO | Tax withholding | 1,267 | $55.75 |
| 2026-05-05 | Lombardi Ronald M. | Chief Executive Officer | Tax withholding | 2,197 | $55.75 |
| 2026-05-05 | Zerillo Jeffrey | Senior VP Operations | Open market sale | 346 | $55.32 |
| 2026-05-04 | Sacco Christine | CFO & COO | Grant / award | 7,008 | $0.00 |
| 2026-05-04 | Sacco Christine | CFO & COO | Tax withholding | 3,434 | $55.31 |
| 2026-05-04 | Sacco Christine | CFO & COO | Grant / award | 11,976 | $0.00 |
| 2026-05-04 | P'Pool William | See Remarks | Grant / award | 3,675 | $0.00 |
| 2026-05-04 | P'Pool William | See Remarks | Tax withholding | 1,888 | $55.31 |
| 2026-05-04 | P'Pool William | See Remarks | Grant / award | 4,187 | $0.00 |
| 2026-05-04 | Zerillo Jeffrey | Senior VP Operations | Grant / award | 2,450 | $0.00 |
| 2026-05-04 | Zerillo Jeffrey | Senior VP Operations | Tax withholding | 1,243 | $55.31 |
| 2026-05-04 | Zerillo Jeffrey | Senior VP Operations | Grant / award | 2,857 | $0.00 |
| 2026-05-04 | Mekhail Adel | EVP, Marketing & Sales | Grant / award | 3,505 | $0.00 |
| 2026-05-04 | Mekhail Adel | EVP, Marketing & Sales | Tax withholding | 1,695 | $55.31 |
| 2026-05-04 | Mekhail Adel | EVP, Marketing & Sales | Grant / award | 4,014 | $0.00 |
| 2026-05-04 | Lombardi Ronald M. | Chief Executive Officer | Grant / award | 31,468 | $0.00 |
| 2026-05-04 | Lombardi Ronald M. | Chief Executive Officer | Tax withholding | 16,789 | $55.31 |
| 2026-05-04 | Lombardi Ronald M. | Chief Executive Officer | Grant / award | 19,662 | $0.00 |
| 2026-05-02 | Sacco Christine | CFO & COO | Tax withholding | 1,091 | $55.09 |
| 2026-05-02 | Zerillo Jeffrey | Senior VP Operations | Tax withholding | 432 | $55.09 |
| 2026-05-02 | Lombardi Ronald M. | Chief Executive Officer | Tax withholding | 2,665 | $55.09 |
| 2026-05-02 | Mekhail Adel | EVP, Marketing & Sales | Tax withholding | 542 | $55.09 |
| 2026-05-02 | P'Pool William | See Remarks | Tax withholding | 599 | $55.09 |
| 2026-02-11 | Zerillo Jeffrey | Senior VP Operations | Open market sale | 1,000 | $65.93 |
| 2026-01-06 | Rosado Jose Luis | See Remarks | Grant / award | 3,426 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:23 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-14 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-08-05 | 4 | 2026-08-04 | View on SEC.gov → |
| 2026-08-05 | 4 | 2026-08-04 | View on SEC.gov → |
| 2026-08-05 | 4 | 2026-08-04 | View on SEC.gov → |
| 2026-08-05 | 4 | 2026-08-04 | View on SEC.gov → |
| 2026-08-05 | 4 | 2026-08-04 | View on SEC.gov → |
| 2026-07-15 | 8-K | 2026-07-15 | View on SEC.gov → |
| 2026-07-06 | 8-K | 2026-06-30 | View on SEC.gov → |
| 2026-06-16 | 8-K | 2026-06-12 | View on SEC.gov → |
| 2026-05-14 | 10-K | 2026-03-31 | View on SEC.gov → |
Recent news
Headlines about PBH (Prestige Consumer Healthcare Inc.). Links open the publisher — we don’t host full articles.
-
Learn to Evaluate (PBH.DB.G) using the Charts
Stock Traders Daily · 2026-10-21 -
(PBH.DB.I) Trading Strategy and Analysis (PBH.DB.I:CA)
Stock Traders Daily · 2026-10-21 -
Prestige Consumer Healthcare sets November 5 results for Prestige Consumer Healthcare stock
AD HOC NEWS · 2026-10-20 -
(PBH.DB.H) Strategic Market Analysis
Stock Traders Daily · 2026-10-20 -
Premium Brands (TSE:PBH) Shares Break Below 200 Day Moving Average - What's Next?
MarketBeat · 2026-10-20 -
Analysts cite USD 67.67 target for Prestige Consumer Healthcare stock
AD HOC NEWS · 2026-10-17 -
Prestige Consumer Healthcare stock falls 11% on Q4 revenue decline
scanx.trade · 2026-10-17 -
Prestige Consumer Healthcare In (PBH) Stock Forecasts
Yahoo! Finance Canada · 2026-10-17
No headlines in this category right now — try “All”.